Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Sanofi Has EU Insulin Aspart Biosimilar Approval
Firm Comments on Pricing And Launch Plans For Rival To NovoRapid
Jul 08 2020
•
By
David Wallace
The European Commission has formally approved Sanofi’s insulin aspart biosimilar • Source: Shutterstock
More from Biosimilars
More from Products
